From: Hepatitis B virus infection and development of chronic kidney disease: a cohort study
Characteristics | Overall | Hepatitis B virus infection | P value | |
---|---|---|---|---|
HBsAg (ā) | HBsAg (+) | |||
Number (%) | 299,913 | 288,704 (96.3) | 11,209 (3.7) | Ā |
Age, years* | 37.3 (7.9) | 37.3 (7.9) | 38.2 (7.6) | <ā 0.001 |
Men, % | 56.7 | 56.4 | 63.7 | <ā 0.001 |
Current smoker, % | 23.6 | 23.6 | 25.1 | <ā 0.001 |
Alcohol intake, g/dayā | 5 (0ā15) | 5 (0ā15) | 4 (0ā13) | <ā 0.001 |
Vigorous exercise, %ā” | 14.2 | 14.2 | 15.7 | <ā 0.001 |
Higher education, %Ā§ | 58.5 | 58.5 | 58.1 | 0.57 |
BMI, kg/m2* | 23.2 (3.2) | 23.2 (3.2) | 23.5 (3.1) | <ā 0.001 |
ALT, U/lā | 19 (14ā29) | 19 (14ā29) | 26 (18ā38) | <ā 0.001 |
AST, U/lā | 21 (18ā26) | 21 (17ā26) | 25 (20ā31) | <ā 0.001 |
GGT, U/lā | 19 (12ā33) | 19 (12ā33) | 20 (13ā33) | <ā 0.001 |
eGFR, ml/min/1.73m2* | 88.2 (16.6) | 88.3 (16.7) | 86.4 (15.2) | <ā 0.001 |
Glucose, mg/dl* | 93.6 (13.7) | 93.6 (13.7) | 93.1 (13.6) | <ā 0.001 |
Hypertension, % | 11.7 | 11.7 | 12.0 | 0.37 |
Diabetes, % | 2.4 | 2.4 | 2.5 | 0.38 |
Fatty liver disease, % | 25.4 | 25.6 | 22.7 | <ā 0.001 |